Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations
暂无分享,去创建一个
P. Moerloose | G. Reber | A. Ruffatti | M. Borghi | V. Pengo | F. Noventa | C. Grossi | A. Cavazzana | M. Tonello
[1] P. Moerloose,et al. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome , 2008, Journal of thrombosis and haemostasis : JTH.
[2] P. de Moerloose,et al. An Analysis of Experimental Conditions Influencing the Anti‐β2‐Glycoprotein I ELISA Assay Results , 2007, Annals of the New York Academy of Sciences.
[3] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[4] Y. Shoenfeld,et al. Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. , 2004, Thrombosis and haemostasis.
[5] S. Iliceto,et al. A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants , 2004, Journal of thrombosis and haemostasis : JTH.
[6] A. Tincani,et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. , 2004, Thrombosis research.
[7] T. Kveder,et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. , 2002, Thrombosis and haemostasis.
[8] G. Hughes,et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. , 1999, Arthritis and rheumatism.
[9] G. Hughes,et al. beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. , 1994, Arthritis and rheumatism.